Geron Corp. buy Slaandjivaa
Start price
16.01.18
/
50%
€1.94
Target price
01.03.18
€2.26
Performance (%)
8.12%
End price
01.03.18
€2.10
Summary
This prediction ended on 01.03.18 with a price of €2.10. With a performance of 8.12%, the BUY prediction by Slaandjivaa for Geron Corp. closed with a slight gain. Slaandjivaa has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Geron Corp. | -1.031% | -1.031% | -58.445% | -62.626% |
| iShares Core DAX® | -1.553% | -0.123% | 12.654% | 57.846% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.546% | 93.736% |
| iShares Nikkei 225® | 1.640% | 5.468% | 17.939% | 51.788% |
| iShares S&P 500 | 0.114% | -0.217% | 1.586% | 61.648% |
Comments by Slaandjivaa for this prediction
In the thread Geron Corp. diskutieren
Gerne Geron
https://seekingalpha.com/article/4137225-toxicity-gerons-imetelstat-may-lead-accelerated-fda-approval